Jay Thomas

Summary

Affiliation: San Diego Hospice
Country: USA

Publications

  1. ncbi Clinical management of dyspnoea
    Jay R Thomas
    Center for Palliative Studies, San Diego Hospice, University of California, San Diego School of Medicine, San Diego, CA, USA
    Lancet Oncol 3:223-8. 2002
  2. ncbi Treatment of dyspnea in cancer patients
    Jay R Thomas
    Center for Palliative Studies, San Diego Hospice and School of Medicine, University of California at San Diego, USA
    Oncology (Williston Park) 16:745-50; discussion 750, 755, 758-60. 2002
  3. ncbi Pain in terminally ill patients: guidelines for pharmacological management
    Jay R Thomas
    Center for Palliative Studies, San Diego Hospice, San Diego School of Medicine, University of California, San Diego, California, USA
    CNS Drugs 17:621-31. 2003
  4. ncbi Management of dyspnea
    Jay R Thomas
    Center for Palliative Studies, San Diego Hospice, a teaching affiliate of the University of California, San Diego School of Medicine, USA
    J Support Oncol 1:23-32; discussion 32-4. 2003
  5. ncbi Intravenous lidocaine relieves severe pain: results of an inpatient hospice chart review
    Jay Thomas
    San Diego Hospice and Palliative Care, San Diego, California 92103, USA
    J Palliat Med 7:660-7. 2004
  6. ncbi Strategies to manage constipation
    Jay Thomas
    San Diego Hospice and Palliative Care, USA
    J Support Oncol 4:220, 223. 2006
  7. doi Methylnaltrexone for opioid-induced constipation in advanced illness
    Jay Thomas
    San Diego Hospice and the Institute for Palliative Medicine, San Diego, CA 92103, USA
    N Engl J Med 358:2332-43. 2008
  8. ncbi Opioid-induced bowel dysfunction
    Jay Thomas
    San Diego Hospice and Palliative Care, San Diego, California 92103, USA
    J Pain Symptom Manage 35:103-13. 2008
  9. doi Optimizing opioid management in palliative care
    Jay Thomas
    San Diego Hospice and Palliative Care, Department of Medicine, University of California San Diego, San Diego, California, USA
    J Palliat Med 10:S1-18; quiz S19-23. 2007
  10. ncbi Cancer-related constipation
    Jay Thomas
    San Diego Hospice and Palliative Care, San Diego, San Diego, CA 92103, USA
    Curr Oncol Rep 9:278-84. 2007

Detail Information

Publications12

  1. ncbi Clinical management of dyspnoea
    Jay R Thomas
    Center for Palliative Studies, San Diego Hospice, University of California, San Diego School of Medicine, San Diego, CA, USA
    Lancet Oncol 3:223-8. 2002
    ..In rare cases for which symptomatic treatment does not control dyspnoea to the patient's satisfaction, sedation is an effective, ethical option...
  2. ncbi Treatment of dyspnea in cancer patients
    Jay R Thomas
    Center for Palliative Studies, San Diego Hospice and School of Medicine, University of California at San Diego, USA
    Oncology (Williston Park) 16:745-50; discussion 750, 755, 758-60. 2002
    ..When prescribed appropriately, respiratory depression is not a significant concern. In the rare cases in which opioids are unable to control dyspnea, sedation is an effective, ethical, and legal option...
  3. ncbi Pain in terminally ill patients: guidelines for pharmacological management
    Jay R Thomas
    Center for Palliative Studies, San Diego Hospice, San Diego School of Medicine, University of California, San Diego, California, USA
    CNS Drugs 17:621-31. 2003
    ..Given the complex aetiology of pain states, combinations of classes of adjuvants may sometimes be needed for effective treatment...
  4. ncbi Management of dyspnea
    Jay R Thomas
    Center for Palliative Studies, San Diego Hospice, a teaching affiliate of the University of California, San Diego School of Medicine, USA
    J Support Oncol 1:23-32; discussion 32-4. 2003
    ..In rare cases where symptomatic treatment is unable to control dyspnea to the patient's satisfaction, sedation is an effective, ethical option...
  5. ncbi Intravenous lidocaine relieves severe pain: results of an inpatient hospice chart review
    Jay Thomas
    San Diego Hospice and Palliative Care, San Diego, California 92103, USA
    J Palliat Med 7:660-7. 2004
    ..Parenteral lidocaine has been reported to relieve neuropathic pain and/or pain refractory to opioid therapy...
  6. ncbi Strategies to manage constipation
    Jay Thomas
    San Diego Hospice and Palliative Care, USA
    J Support Oncol 4:220, 223. 2006
  7. doi Methylnaltrexone for opioid-induced constipation in advanced illness
    Jay Thomas
    San Diego Hospice and the Institute for Palliative Medicine, San Diego, CA 92103, USA
    N Engl J Med 358:2332-43. 2008
    ..We investigated the safety and efficacy of subcutaneous methylnaltrexone for treating opioid-induced constipation in patients with advanced illness...
  8. ncbi Opioid-induced bowel dysfunction
    Jay Thomas
    San Diego Hospice and Palliative Care, San Diego, California 92103, USA
    J Pain Symptom Manage 35:103-13. 2008
    ..Studies to date show promise that these agents may relieve opioid-induced bowel dysfunction in a well-tolerated manner without reversing central analgesia...
  9. doi Optimizing opioid management in palliative care
    Jay Thomas
    San Diego Hospice and Palliative Care, Department of Medicine, University of California San Diego, San Diego, California, USA
    J Palliat Med 10:S1-18; quiz S19-23. 2007
  10. ncbi Cancer-related constipation
    Jay Thomas
    San Diego Hospice and Palliative Care, San Diego, San Diego, CA 92103, USA
    Curr Oncol Rep 9:278-84. 2007
    ..Preliminary results in cancer-related constipation suggest that these agents may be important additions to our treatment repertoire...
  11. ncbi The symptomatic relief of dyspnea
    Giovanni Elia
    San Diego Hospice and Palliative Medicine, 4311 Third Avenue, San Diego, CA 92103, USA
    Curr Oncol Rep 10:319-25. 2008
    ....
  12. ncbi Assessing the role of human recombinant hyaluronidase in gravity-driven subcutaneous hydration: the INFUSE-LR study
    Jay R Thomas
    San Diego Hospice and Palliative Care, San Diego, California
    J Palliat Med 10:1312-20. 2007
    ..Subcutaneous hydration has potential advantages over intravenous. Despite studies supporting the efficacy and safety of subcutaneous hydration it has not been studied extensively to date either with or without hyaluronidase...